2022
DOI: 10.1016/j.molmed.2022.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Nutrition interventions in congenital disorders of glycosylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 89 publications
0
8
0
Order By: Relevance
“…The transport of monosaccharides provides the cell with energy and metabolic precursors used for a diverse range of processes. Understanding how these sugars are transported and utilized becomes especially important since various diseases/disorders (LADII, GFUS-CDG, SLC35A2-CDG, PGM1-CDG, colitis, various cancers) are already using or exploring “monosaccharide therapy” ( 9 , 20 , 21 ).…”
Section: Discussionmentioning
confidence: 99%
“…The transport of monosaccharides provides the cell with energy and metabolic precursors used for a diverse range of processes. Understanding how these sugars are transported and utilized becomes especially important since various diseases/disorders (LADII, GFUS-CDG, SLC35A2-CDG, PGM1-CDG, colitis, various cancers) are already using or exploring “monosaccharide therapy” ( 9 , 20 , 21 ).…”
Section: Discussionmentioning
confidence: 99%
“…Possibly, 1-2% of the genome produces glycan biosynthesis-related proteins, such as glycosyltransferases, glycosidases, and transporters. Carbohydrate biosynthesis does not follow "the central dogma," [87] but several factors instead [88], such as levels, activities, and trafficking of glycosyltransferases, availabilities of carriers and nucleotide sugar substrates, different physiological functions and statuses, and a variety of outer stimuli [89], such as nutrition [89], oxidative stress [90], and so on.…”
Section: Lectin Microarray a "Sugar Decipher" For Sperm Surface Glyco...mentioning
confidence: 99%
“…Fortunately, a considerable effort has been made in the last decades to improve treatment for this group of disorders, targeting both the genetic causes and the phenotypic consequences [132]. IEMs with a characteristic metabolic phenotype can sometimes be treated with dietary restrictions [13,130] and/or with the use of enzyme inhibitors to avoid the accumulation of metabolic by-products [28]. Yet, small molecule drugs often work by minimizing symptoms rather than curing the disease.…”
Section: Therapeutic Interventions In Rds Other Than Pcmentioning
confidence: 99%